The short-acting insulin industry is rapidly evolving with innovation in formulation and delivery methods driving renewed interest and investment. Healthcare providers and patients are increasingly focused on optimizing glycemic control with faster-acting analogues, leading to significant business growth opportunities in this sector aligned with rising diabetes prevalence worldwide.Market Size...